Cargando…
Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review
Novel targeted anti-cancer therapies have resulted in improvement in patient survival compared to standard chemotherapy. Renal toxicities of targeted agents are increasingly being recognized. The incidence, severity, and pattern of renal toxicities may vary according to the respective target of the...
Autores principales: | Jhaveri, Kenar D., Wanchoo, Rimda, Sakhiya, Vipulbhai, Ross, Daniel W., Fishbane, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720524/ https://www.ncbi.nlm.nih.gov/pubmed/29318210 http://dx.doi.org/10.1016/j.ekir.2016.09.055 |
Ejemplares similares
-
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19
por: Ng, Jia H., et al.
Publicado: (2020) -
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury
por: Ng, Jia H., et al.
Publicado: (2021) -
SAT-128 Evaluating the Accuracy of Glycemic Markers and Risk of Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease by Continuous Glucose Monitoring
por: Presswala, Lubaina, et al.
Publicado: (2019) -
Renal involvement in chronic lymphocytic leukemia
por: Wanchoo, Rimda, et al.
Publicado: (2018) -
Renal effects of BRAF inhibitors: a systematic review by the Cancer and the Kidney International Network
por: Wanchoo, Rimda, et al.
Publicado: (2016)